Utility of myocardial fractional flow reserve for prediction of restenosis following sirolimus-eluting stent implantation-Reference-Cited by-同舟云学术

Utility of myocardial fractional flow reserve for prediction of restenosis following sirolimus-eluting stent implantation

Published:2011-01-08 Issue:6 Volume:26 Page:572-581
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Ishii Hideshi,Kataoka Toru,Kobayashi Yoshiki,Tsumori Takara,Takeshita Hiroaki,Matsumoto Ryo,Shirai Nobuyuki,Nishioka Hiroki,Hasegawa Takao,Nakata Shinji,Shimada Yoshihisa,Ehara Shoichi,Muro Takashi,Yoshiyama Minoru

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-010-0105-1.pdf

Reference31 articles.

1. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350(3):221–231

2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349(14):1315–1323

3. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, Leon MB, Moses JW, Yock PG, Honda Y, Kuntz RE, Fitzgerald PJ (2004) Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol 43(11):1959–1963

4. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, McFadden E, Sianos G, Smits PC, Hofma SH, de Feyter PJ, van Domburg RT, Serruys PW (2004) Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 109(11):1366–1370

5. Kastrati A, Dibra A, Mehilli J, Mayer S, Pinieck S, Pache J, Dirschinger J, Schomig A (2006) Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 113(19):2293–2300

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologic Assessment After Percutaneous Coronary Interventions and Functionally Optimized Revascularization;Cardiology Clinics;2024-02

2. Clinical Implications of Fractional Flow Reserve Measured Immediately After Percutaneous Coronary Intervention;Cardiovascular Drugs and Therapy;2023-02-23

3. Clinical Implications of Fractional Flow Reserve Measured Immediately after Percutaneous Coronary Intervention;2023-01-05

4. Physiologic Assessment After Percutaneous Coronary Interventions and Functionally Optimized Revascularization;Interventional Cardiology Clinics;2023-01

5. Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial;Circulation: Cardiovascular Interventions;2022-11